AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM)
Publication
, Conference
Rosenthal, MA; Balana, C; van Linde, ME; Sayehli, C; Fiedler, WM; Wermke, M; Massard, C; Mellinghoff, IK; Khasraw, M; Ang, A; Rasmussen, E ...
Published in: NEURO-ONCOLOGY
November 1, 2019
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2019
Volume
21
Start / End Page
283 / 283
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rosenthal, M. A., Balana, C., van Linde, M. E., Sayehli, C., Fiedler, W. M., Wermke, M., … Cloughesy, T. F. (2019). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). In NEURO-ONCOLOGY (Vol. 21, pp. 283–283). Phoenix, AZ: OXFORD UNIV PRESS INC.
Rosenthal, Mark A., Carmen Balana, Myra E. van Linde, Cyrus Sayehli, Walter M. Fiedler, Martin Wermke, Christophe Massard, et al. “AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM).” In NEURO-ONCOLOGY, 21:283–283. OXFORD UNIV PRESS INC, 2019.
Rosenthal MA, Balana C, van Linde ME, Sayehli C, Fiedler WM, Wermke M, et al. AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 283–283.
Rosenthal, Mark A., et al. “AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM).” NEURO-ONCOLOGY, vol. 21, OXFORD UNIV PRESS INC, 2019, pp. 283–283.
Rosenthal MA, Balana C, van Linde ME, Sayehli C, Fiedler WM, Wermke M, Massard C, Mellinghoff IK, Khasraw M, Ang A, Rasmussen E, Kast J, Stienen S, Cloughesy TF. AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 283–283.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2019
Volume
21
Start / End Page
283 / 283
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences